Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2001) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 12.716 Q1 | 254 | 22 | 66 | 7351 | 1862 | 65 | 23.55 | 334.14 |  |
| 2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.536 Q1 | 70 | 6 | 43 | 1620 | 277 | 43 | 5.84 | 270.00 |  |
| 3 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 |  |
| 4 | Natural Product Reports | journal | 2.341 Q1 | 211 | 34 | 115 | 7237 | 593 | 114 | 5.95 | 212.85 | |
| 5 | Progress in Medicinal Chemistry | journal | 1.288 Q1 | 38 | 8 | 19 | 1459 | 55 | 6 | 3.31 | 182.38 |  |
| 6 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.898 Q1 | 99 | 10 | 35 | 1795 | 182 | 35 | 5.52 | 179.50 | |
| 7 | Pharmacology and Therapeutics | journal | 2.763 Q1 | 233 | 55 | 189 | 9848 | 1363 | 187 | 5.89 | 179.05 | |
| 8 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.244 Q1 | 82 | 16 | 40 | 2641 | 168 | 40 | 3.15 | 165.06 | |
| 9 | Annual Review of Pharmacology and Toxicology | journal | 10.621 Q1 | 224 | 33 | 65 | 4729 | 1431 | 64 | 21.27 | 143.30 | |
| 10 | Anti-Cancer Agents in Medicinal Chemistry | journal | 108 | 18 | 0 | 2221 | 0 | 0 | 0.00 | 123.39 |  | |
| 11 | Drug Metabolism Reviews | journal | 1.116 Q1 | 108 | 15 | 100 | 1823 | 304 | 100 | 2.99 | 121.53 | |
| 12 | Reviews in Toxicology | journal | 0.329 Q3 | 21 | 5 | 44 | 603 | 37 | 43 | 0.38 | 120.60 | |
| 13 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
| 14 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 45 | 8 | 0 | 945 | 0 | 0 | 0.00 | 118.13 | | |
| 15 | Current Drug Targets | journal | 0.238 Q3 | 119 | 29 | 21 | 3384 | 16 | 21 | 0.76 | 116.69 | |
| 16 | Current Gene Therapy | journal | 80 | 24 | 0 | 2797 | 0 | 0 | 0.00 | 116.54 | | |
| 17 | Current Pharmaceutical Design | journal | 1.153 Q1 | 183 | 115 | 219 | 13310 | 742 | 192 | 3.17 | 115.74 | |
| 18 | Current Cancer Drug Targets | journal | 103 | 16 | 0 | 1772 | 0 | 0 | 0.00 | 110.75 | | |
| 19 | Medicinal Research Reviews | journal | 1.632 Q1 | 150 | 28 | 74 | 3075 | 382 | 73 | 5.54 | 109.82 | |
| 20 | CNS Drug Reviews | journal | 0.254 Q3 | 64 | 23 | 96 | 2299 | 60 | 96 | 0.61 | 99.96 | |
| 21 | Current Medicinal Chemistry | journal | 1.951 Q1 | 202 | 122 | 166 | 11854 | 930 | 154 | 5.79 | 97.16 | |
| 22 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
| 23 | Infectious Disorders - Drug Targets | journal | 61 | 27 | 0 | 2515 | 0 | 0 | 0.00 | 93.15 | | |
| 24 | Current Pharmaceutical Biotechnology | journal | 0.184 Q3 | 97 | 29 | 23 | 2659 | 17 | 23 | 0.74 | 91.69 | |
| 25 | Cellular and Molecular Life Sciences | journal | 2.575 Q1 | 261 | 183 | 547 | 16769 | 2344 | 533 | 4.40 | 91.63 |  |
| 26 | Current Drug Metabolism | journal | 0.329 Q2 | 122 | 28 | 20 | 2547 | 16 | 20 | 0.80 | 90.96 | |
| 27 | Current Topics in Medicinal Chemistry | journal | 133 | 40 | 0 | 3529 | 0 | 0 | 0.00 | 88.23 | | |
| 28 | Annual Report of Shionogi Research Laboratory | journal | 0.103 Q4 | 2 | 1 | 6 | 87 | 0 | 6 | 0.00 | 87.00 |  |
| 29 | Expert Opinion on Biological Therapy | journal | 102 | 84 | 0 | 6963 | 0 | 0 | 0.00 | 82.89 | | |
| 30 | Mini-Reviews in Medicinal Chemistry | journal | 107 | 38 | 0 | 3149 | 0 | 0 | 0.00 | 82.87 | | |
| 31 | Critical Reviews in Toxicology | journal | 2.297 Q1 | 129 | 36 | 38 | 2962 | 281 | 37 | 6.96 | 82.28 | |
| 32 | Advanced Drug Delivery Reviews | journal | 1.091 Q1 | 366 | 162 | 316 | 13200 | 1079 | 290 | 3.12 | 81.48 | |
| 33 | Drug Resistance Updates | journal | 0.727 Q1 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | |
| 34 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 39 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
| 35 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 12 | 17 | 0 | 1305 | 0 | 0 | 0.00 | 76.76 | | |
| 36 | Drug Safety | journal | 1.019 Q1 | 140 | 86 | 238 | 6344 | 955 | 231 | 3.96 | 73.77 | |
| 37 | Anales de la Real Academia Nacional de Farmacia (discontinued) | journal | 0.115 Q4 | 10 | 3 | 34 | 215 | 3 | 34 | 0.04 | 71.67 |  |
| 38 | Apoptosis : an international journal on programmed cell death | journal | 0.446 Q1 | 128 | 47 | 159 | 3353 | 143 | 159 | 0.89 | 71.34 | |
| 39 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
| 40 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
| 41 | Cardiovascular Drug Reviews | journal | 0.299 Q3 | 54 | 25 | 80 | 1597 | 59 | 80 | 0.52 | 63.88 | |
| 42 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 117 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
| 43 | Cutaneous and Ocular Toxicology | journal | 0.124 Q4 | 37 | 27 | 128 | 1630 | 17 | 109 | 0.10 | 60.37 | |
| 44 | Combinatorial Chemistry and High Throughput Screening | journal | 0.780 Q1 | 70 | 60 | 94 | 3583 | 260 | 89 | 2.49 | 59.72 | |
| 45 | Clinical Pharmacokinetics | journal | 1.435 Q1 | 184 | 75 | 206 | 4310 | 1107 | 198 | 5.14 | 57.47 | |
| 46 | Toxin Reviews | journal | 0.348 Q3 | 54 | 15 | 90 | 859 | 63 | 87 | 0.81 | 57.27 | |
| 47 | Neurotoxicity Research | journal | 84 | 45 | 1 | 2485 | 0 | 1 | 0.00 | 55.22 | | |
| 48 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.552 Q2 | 150 | 102 | 291 | 5448 | 384 | 291 | 1.22 | 53.41 | |
| 49 | Expert Opinion on Therapeutic Patents | journal | 0.404 Q2 | 88 | 126 | 429 | 6674 | 437 | 424 | 1.02 | 52.97 | |
| 50 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.167 Q3 | 29 | 20 | 24 | 1058 | 8 | 22 | 0.27 | 52.90 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data